GH509

N/A

Report date: 2022/08/16 14:32:58
NME

Base Information

Drug NameGH509
Drug Alias NameGH-509
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator Companies1globe Biomedical Co LtdQuotient Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQuotient Sciences - Philadelphia LlcSharp Packaging Solutions1globe Health Llc +[4] 
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A